Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Clinical

  • 1
    News

    Dapagliflozin’s CKD performance sends heart failure messages

    October 5, 2020

    The recently reported DAPA-CKD trial results focused on patients with renal disease, but the findings also resonate for heart failure clinicians.

  • News

    Real-world safety, efficacy found for fecal transplants

    October 2, 2020

    The study didn't yield any findings on indications other than Clostridioides difficile. "In no way, shape, or form does it mean you can use it for autism, depression, heart disease, or [irritable bowel syndrome]."

  • News

    Post-COVID clinics get jump-start from patients with lingering illness

    October 2, 2020

    That need has jump-started post-COVID clinics, which bring together a range of specialists into a one-stop shop.

  • News

    AHA scientific statement highlights cardiorenal benefit of new diabetes drugs

    October 1, 2020

    SGLT2 inhibitors and GLP-1 receptor agonists should be considered in people with type 2 diabetes and chronic kidney disease to protect against heart disease and kidney disease progression.

  • 1
    News

    COVID-19 shutdown fuels sharp rise in alcohol use

    September 30, 2020

    After some states issued stay-at-home orders, one study noted a 54% increase in national sales of alcohol for the week ending March 21, compared with 1 year earlier.

  • 1
    News

    DAPA-CKD resets eGFR floor for safe SGLT2 inhibitor use

    September 25, 2020

    Until now, SGLT2 inhibitors were for patients with an eGFR of at least 30 mL/min per m2. New evidence moves the threshold down to 25.

  • 1
    News

    COVID-19 airway management: Expert tips on infection control

    September 24, 2020

    “We will always observe standard precautions, which include hand hygiene, gloves, hair and eye cover, medical mask, and face shield,” Dr. Charles Griffis said.

  • News

    J&J’s one-shot COVID-19 vaccine advances to phase 3 testing

    September 24, 2020

    J&J’s vaccine is unusual in that it will be tested based on a single dose, while other advanced candidates have been tested in two-dose regimens.

  • News

    CDC playbook prepares states for rollout of COVID-19 vaccine if one is approved

    September 24, 2020

    The agency has asked states to submit plans for vaccine distribution by mid-October.

  • News

    Three major COVID vaccine developers release detailed trial protocols

    September 23, 2020

    Typically, manufacturers guard the specifics of preclinical vaccine trials. This rare move follows calls for greater transparency.

Previous1 … 108 109 110 111 112 … 401Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences